Cingulate Inc Bolsters Board, Targets Nasdaq Compliance

Cingulate Inc (CING) has released an update.

Cingulate Inc. has appointed three new independent directors to its Board, bringing diverse expertise from healthcare, finance, and biotech sectors. Bryan Lawrence, Jeffrey S. Ervin, and John A. Roberts will serve on key company committees, with Roberts recognized as an “audit committee financial expert.” These appointments follow the company’s strategy to regain compliance with Nasdaq’s listing rules after facing delisting due to non-compliance issues. With recent corporate restructuring and capital raising efforts, Cingulate Inc. is optimistic about meeting Nasdaq’s equity and governance standards to maintain its listing.

For further insights into CING stock, check out TipRanks’ Stock Analysis page.